Covaxin for children

Emergency use authorization request filed with FDA for paediatric use of Bharat Biotech's Covaxin

The submission is based on the results of a Phase 2/3 paediatric clinical trial conducted by Bharat Biotech in India with 526 children 2-18 years of age.

published on : 5th November 2021

Doctors welcome expert panel's suggestion on Covaxin for children; flag issue of global acceptance

Efforts must be made to establish its efficacy globally so that the children are not subject to restrictive measures when they travel abroad, they said.

published on : 12th October 2021